LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...

Findings could inform the design of artificial tissues and organs, presenting a potential route for delivering nutrients or therapies.

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

Two biotech innovators launched products that solve challenges in gene therapy scale-up and learn from omics data from ...

The facility will be built to meet SFDA, FDA, EMA, and BMBL requirements and will include a fully integrated digital manufacturing platform.

When tested in a mouse model of breast cancer, the doxorubicin-loaded nanoparticles caused fewer side effects than free ...

Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines.